Patents by Inventor Mohammed Pervez

Mohammed Pervez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190100498
    Abstract: The application relates to a crystalline form of the compound of formula (I).
    Type: Application
    Filed: March 24, 2016
    Publication date: April 4, 2019
    Inventors: Thomas LANGER, Paul Allen BETHEL, Mohammed PERVEZ, Lai Chun CHAN, Sophie JANBON
  • Patent number: 9562017
    Abstract: The present invention relates to Compound 1 hydrogen sulfate salt and solvates, crystalline forms and amorphous forms thereof, and to processes for their preparation.
    Type: Grant
    Filed: April 28, 2015
    Date of Patent: February 7, 2017
    Assignees: AsrtaZeneca AB, Array BioPharma Inc.
    Inventors: John DeMattei, Tsung-Hsun Chuang, Gorkhn Sharma-Singh, Paul Alfred Dickinson, Mohammed Pervez, Richard Anthony Storey, Christopher John Squire, James Gair Ford, Ronald John Roberts
  • Publication number: 20160024018
    Abstract: The present invention relates to Compound 1 hydrogen sulfate salt and solvates, crystalline forms and amorphous forms thereof, and to processes for their preparation.
    Type: Application
    Filed: April 28, 2015
    Publication date: January 28, 2016
    Inventors: John DeMattei, Tsung-Hsun Chuang, Gorkhn Sharma-Singh, Paul Alfred Dickinson, Mohammed Pervez, Richard Anthony Storey, Christopher John Squire, James Gair Ford, Ronald John Roberts
  • Patent number: 9156795
    Abstract: The present invention relates to Compound 1 hydrogen sulfate salt and solvates, crystalline forms and amorphous forms thereof, and to processes for their preparation.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: October 13, 2015
    Assignees: Array BioPharma, Inc., Astrazeneca AB
    Inventors: John DeMattei, Tsung-Hsun Chuang, Christopher John Squire, Ronald John Roberts, Gorkhn Sharma-Singh, Mohammed Pervez, James Gair Ford, Richard Anthony Storey, Paul Alfred Dickinson
  • Publication number: 20140221443
    Abstract: The present invention relates to Compound 1 hydrogen sulfate salt and solvates, crystalline forms and amorphous forms thereof, and to processes for their preparation.
    Type: Application
    Filed: January 10, 2014
    Publication date: August 7, 2014
    Applicants: Astrazeneca AB, Array BioPharma Inc.
    Inventors: John DeMattei, Tsung-Hsun Chuang, Gorkhn Sharma-Singh, Paul Alfred Dickinson, Mohammed Pervez, Richard Anthony Storey, Christopher John Squire, James Gair Ford, Ronald John Roberts
  • Publication number: 20120253049
    Abstract: The present invention relates to Compound 1 hydrogen sulfate salt and solvates, crystalline forms and amorphous forms thereof, and to processes for their preparation.
    Type: Application
    Filed: May 3, 2012
    Publication date: October 4, 2012
    Inventors: John DeMattei, Tsung-Hsun Chuang, Christopher John Squire, Ronald John Roberts, Gorkhn Sharma-Singh, Mohammed Pervez, James Gair Ford, Richard Anthony Storey, Paul Alfred Dickinson
  • Publication number: 20100016393
    Abstract: The present invention relates to Compound 1 hydrogen sulfate salt and solvates, crystalline forms and amorphous forms thereof, and to processes for their preparation.
    Type: Application
    Filed: December 12, 2006
    Publication date: January 21, 2010
    Inventors: John DeMattei, Tsung-Hsun Chuang, Christopher John Squire, Ronald John Roberts, Gorkhn Sharma-Singh, Mohammed Pervez, James Gair Ford, Richard Anthony Storey, Paul Alfred Dickinson
  • Publication number: 20090030058
    Abstract: The present invention relates to a tosylate salt of Compound 1 and polymorphs thereof, in particular crystalline and amorphous forms of Compound 1 tosylate salt, and methods of preparation thereof. Pharmaceutical compositions containing these salts as active ingredient, their use in the manufacture of medicaments for use in the treatment and/or prophylaxis of proliferative disease states, such as cancer, in the human or animal body, and their use in methods for the treatment and/or prophylaxis of proliferative disease states, such as cancer, in the human or animal body are also described.
    Type: Application
    Filed: December 18, 2006
    Publication date: January 29, 2009
    Inventors: Mohammed Pervez, Ronald John Roberts, Christopher John Squire, Richard Anthony Storey
  • Patent number: 6737530
    Abstract: A new process for the preparation of 4-(4-pyridinyl)benzoic acid, or a salt thereof.
    Type: Grant
    Filed: October 23, 2002
    Date of Patent: May 18, 2004
    Assignee: AstraZeneca AB
    Inventor: Mohammed Pervez
  • Publication number: 20030166942
    Abstract: A new process for the preparation of 4-(4-pyridinyl)benzoic acid, or a salt thereof.
    Type: Application
    Filed: October 23, 2002
    Publication date: September 4, 2003
    Inventor: Mohammed Pervez